1.66

3.11% 0.05

After Hours: 1.68 0.02 +1.20%

Opko Health Inc (OPK)

Overview News Price History Option Chain Financials Discussions Forecast

Opko Health Inc stock is traded at $1.66, with a volume of 4.34M. It is up +3.11% in the last 24 hours and down -0.60% over the past month. OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Previous Close:

$1.61

Open:

$1.63

24h Volume:

4.34M

Relative Volume:

0.51

Market Cap:

$1.24B

Revenue:

$581.12M

Net Income/Loss:

$-212.92M

P/E Ratio:

-6.0628

EPS:

-0.2738

Net Cash Flow:

$-174.22M

1W Performance:

+25.76%

1M Performance:

-0.60%

6M Performance:

+36.07%

1Y Performance:

+8.50%

1-Day Range:

$1.62

$1.73

1-Week Range:

$1.30

$1.77

52-Week Range:

$0.9769

$1.77

Opko Health Inc Stock (OPK) Company Profile

Name

Opko Health Inc

Sector

Healthcare (1052)

Industry

Diagnostics & Research (44)

Phone

305-575-4181

Address

4400 BISCAYNE BLVD., MIAMI, FL

Employee

2,275

Twitter

Next Earnings Date

2026-11-04

Latest SEC Filings

OPK's Discussions on Twitter

Compare OPK vs TMO, DHR, NTRA, A, IQV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPK Opko Health Inc	1.66	1.24B	581.12M	-212.92M	-174.22M	-0.2738
TMO Thermo Fisher Scientific Inc	687.37	254.15B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	224.24	157.64B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	405.92	58.51B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	173.01	48.78B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	267.85	44.09B	16.63B	1.39B	2.12B	8.0674

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-16-26	Upgrade	Barrington Research	Mkt Perform → Outperform
Apr-29-26	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-20-25	Initiated	JP Morgan	Neutral
Oct-31-25	Downgrade	Jefferies	Buy → Hold
Apr-25-25	Initiated	JP Morgan	Neutral
Jun-29-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Dec-15-22	Initiated	H.C. Wainwright	Buy
Jan-24-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Jun-21-21	Initiated	Ladenburg Thalmann	Buy
Nov-25-19	Initiated	Piper Jaffray	Overweight
Mar-02-18	Downgrade	JP Morgan	Neutral → Underweight
Sep-14-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-21-16	Reiterated	Standpoint Research	Buy
Jun-03-16	Initiated	Standpoint Research	Buy
Mar-31-16	Reiterated	Barrington Research	Outperform
Oct-16-15	Initiated	JP Morgan	Overweight
Sep-11-15	Downgrade	Jefferies	Buy → Hold
Mar-03-15	Downgrade	Oppenheimer	Outperform → Perform
May-12-14	Reiterated	Oppenheimer	Outperform
Mar-14-14	Initiated	Oppenheimer	Outperform
Nov-13-13	Reiterated	Ladenburg Thalmann	Buy
May-30-13	Reiterated	Ladenburg Thalmann	Buy
Oct-22-12	Initiated	Barrington Research	Outperform
Dec-01-11	Reiterated	Ladenburg Thalmann	Buy
Jul-14-11	Initiated	Ladenburg Thalmann	Buy

View All

Opko Health Inc Stock (OPK) Latest News

Oct 17, 2026

OPKO Health (OPK) Sells BioReference Assets On A Valuation Story That Still Divides - Yahoo Finance

Oct 17, 2026

Is OPKO Health (OPK) Pricing In Too Much For Sales? - Yahoo Finance

Oct 17, 2026

OPKO Health to Sell Select BioReference Assets to Labcorp for $722M - Zacks Investment Research

Oct 17, 2026

Oct 16, 2026